Ireland - English - HPRA (Health Products Regulatory Authority)

gedeon richter plc - ethinylestradiol, gestodene - transdermal patch - progestogens and estrogens, fixed combinations

Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - gestodene, ethinylestradiol - transdermal patch - gestodene 2.1 mg ethinylestradiol 0.55 mg - sex hormones and modulators of the genital system

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 2.52mg equivalent to 0.1 mg/24hr - transdermal patch - 0.1 mg/24h - active: clonidine 2.52mg equivalent to 0.1 mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 5.04mg equivalent to 0.2 mg/24hr - transdermal patch - 0.2 mg/24h - active: clonidine 5.04mg equivalent to 0.2 mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 7.56mg equivalent to 0.3mg/24hr - transdermal patch - 0.3 mg/24h - active: clonidine 7.56mg equivalent to 0.3mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - estradiol - transdermal patch - 100microgram/24hour

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - estradiol - transdermal patch - 50microgram/24hour

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - glyceryl trinitrate 25mg (releasing 5mg/24h) - transdermal patch - 5 mg/24h - active: glyceryl trinitrate 25mg (releasing 5mg/24h) - treatment of angina pectoris as monotherapy or in combination with other anti-anginal drugs such as beta-blockers and/or calcium antagonists.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - glyceryl trinitrate 50mg (releasing 10mg/24h) - transdermal patch - 10 mg/24h - active: glyceryl trinitrate 50mg (releasing 10mg/24h) - treatment of angina pectoris as monotherapy or in combination with other anti-anginal drugs such as beta-blockers and/or calcium antagonists.